Vaccination figures now available by municipality RIVM is providing access to COVID-19 vaccination figures by municipality via open data as of today. The open data now includes vaccination turnout and coverage by municipality for three age groups.
More attention needed for mental health refugees Although the physical health of asylum seekers holding a temporary residence permit (permit holders) is relatively good, this is to a much lesser extent the case with respect to mental health.
New international project Inno4Vac targets faster vaccine development Inno4vac, a new European interdisciplinary project was launched on 1 September. Inno4vac focuses on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of new vaccines.
Dust in IJmond contains many PAHs and metals In Wijk aan Zee, Beverwijk, Velsen-Noord and IJmuiden, more polycyclic aromatic hydrocarbons (PAHs) and metals were found in the deposition of dust than outside the IJmond region.
Update on RIVM report “Silicone breast implants in the Netherlands”, State of Affairs October 2017 In June 2016, RIVM published the results of a study on breast implants in the Netherlands.
RIVM to contribute to new Horizon2020 project on oceans and human health across Europe A new EU Horizon2020 project Seas, Oceans and Public Health in Europe (SOPHIE) will explore the complex interplay between the health of the marine environment and that of humans.
Dutch collaboration in One Health European Joint Programme (EJP) RIVM, Wageningen Bioveterinary Research (WBVR) and the Netherlands Centre for One Health (NCOH) are involved in a recently granted One Health European Joint Programme which will start in January 20
Survey health complaints of women with a silicone breast implant This report provides a broad overview of the health complaints experienced by women with silicone breast implants in the Netherlands.
Efficiency and transparency of clinical drug trials must improve The efficiency and transparency of clinical drug trials in the Netherlands must improve. That concludes Sander van den Bogert in his PhD thesis ‘Trials & Tribulations.